Assets, Current of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Assets, Current in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Assets, Current for the quarter ending 31 Dec 2024 was $601,602, a 84% increase year-over-year.
Source SEC data: View on sec.gov

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$601,602	+$274,427	+84%	31 Dec 2024	20-F	13 Jun 2025	2024	FY
Q4 2023	$327,175	-$174,377	-35%	31 Dec 2023	20-F/A	23 Sep 2025	2023	FY
Q3 2023	$52,135			30 Sep 2023	6-K	13 Nov 2023	2023	Q3
Q4 2022	$501,552	-$629,276	-56%	31 Dec 2022	20-F/A	23 Sep 2025	2023	FY
Q4 2021	$1,130,828	+$181,821	+19%	31 Dec 2021	20-F	15 May 2023	2022	FY
Q4 2020	$949,007			31 Dec 2020	20-F	15 May 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.